HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Robbins Selected Research

Ventricular Myosins

2/2010Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function.
7/2008Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
12/2004Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
10/2002Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition.
6/2002Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey Robbins Research Topics

Disease

30Heart Failure
01/2020 - 04/2002
26Cardiomyopathies (Cardiomyopathy)
12/2018 - 11/2003
18Heart Diseases (Heart Disease)
01/2020 - 12/2002
16Hypertrophy
10/2021 - 04/2002
10Fibrosis (Cirrhosis)
12/2018 - 04/2002
9Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
09/2013 - 12/2002
8Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2018 - 10/2002
7Cardiomegaly (Heart Hypertrophy)
12/2018 - 05/2004
6Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
10/2018 - 07/2002
4Myocardial Infarction
09/2017 - 08/2007
4Reperfusion Injury
01/2017 - 04/2009
4Ischemia
08/2013 - 01/2008
4Desmin-Related Myofibrillar Myopathy
10/2011 - 04/2007
4Neurodegenerative Diseases (Neurodegenerative Disease)
07/2010 - 04/2007
3Cardiovascular Diseases (Cardiovascular Disease)
09/2017 - 12/2014
3Infarction (Infarctions)
03/2012 - 10/2007
3Noonan Syndrome (Female Pseudo-Turner Syndrome)
09/2009 - 10/2005
3Necrosis
04/2008 - 03/2005
2Proteostasis Deficiencies
01/2020 - 09/2011
2Infections
01/2018 - 03/2009
2Glycogen Storage Disease Type IIb
10/2017 - 01/2008
2Sudden Death
04/2014 - 02/2010
2Myocardial Ischemia (Ischemic Heart Diseases)
03/2012 - 09/2011
2Mitochondrial Diseases (Mitochondrial Disease)
10/2011 - 11/2005
1Diabetes Mellitus
01/2021
1Cardiotoxicity
01/2019
1Absent corpus callosum cataract immunodeficiency
10/2017
1LEOPARD Syndrome (Syndrome, LEOPARD)
10/2017
1Acute Kidney Injury (Acute Renal Failure)
01/2017
1Disease Progression
03/2016
1Restrictive Cardiomyopathy
12/2014
1Diastolic Heart Failure
04/2014
1Inborn Genetic Diseases (Disease, Hereditary)
04/2014
1Rupture
08/2013
1Stroke (Strokes)
01/2013
1Obesity
03/2012
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2012

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2002
22DesminIBA
11/2018 - 12/2002
12Crystallins (Crystallin)IBA
10/2018 - 12/2002
9Protein Isoforms (Isoforms)IBA
02/2014 - 09/2003
6Amyloid (Amyloid Fibrils)IBA
10/2011 - 07/2004
5Myosins (Myosin)IBA
10/2018 - 07/2008
5CalcineurinIBA
06/2010 - 04/2002
5Ventricular MyosinsIBA
02/2010 - 06/2002
4Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020 - 04/2007
4Cardiac MyosinsIBA
12/2018 - 05/2010
3Protein AggregatesIBA
01/2020 - 04/2007
3Carrier Proteins (Binding Protein)IBA
12/2018 - 08/2013
3PeriostinIBA
10/2018 - 08/2007
3Doxycycline (Periostat)FDA LinkGeneric
04/2016 - 10/2008
3phospholambanIBA
03/2012 - 04/2008
3Isoproterenol (Isoprenaline)FDA LinkGeneric
12/2009 - 12/2004
3Cyclophilins (Cyclophilin)IBA
04/2008 - 03/2005
3CalciumIBA
04/2008 - 04/2007
3alpha-Crystallin B ChainIBA
11/2005 - 07/2004
2Transforming Growth Factor-beta Type II ReceptorIBA
12/2018 - 10/2018
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
10/2018 - 05/2010
2Transforming Growth Factor beta (TGF-beta)IBA
10/2018 - 12/2014
2Sirolimus (Rapamycin)FDA Link
10/2017 - 06/2014
2Mitogen-Activated Protein KinasesIBA
09/2017 - 10/2005
2Peptides (Polypeptides)IBA
09/2017 - 05/2008
2Tetracycline (Achromycin)FDA LinkGeneric
04/2016 - 08/2011
2cysteine and glycine-rich protein 3IBA
12/2014 - 03/2004
2Mitochondrial Permeability Transition PoreIBA
08/2013 - 09/2007
2Adenosine Triphosphate (ATP)IBA
01/2013 - 03/2008
2Mutant Proteins (Protein, Mutant)IBA
09/2011 - 11/2005
2Protein Tyrosine PhosphatasesIBA
07/2009 - 10/2005
2Phenylephrine (Neo-Synephrine)FDA LinkGeneric
04/2009 - 02/2007
2polyglutamineIBA
08/2008 - 05/2008
2Small Heat-Shock ProteinsIBA
11/2005 - 07/2004
2Connexin 43 (Connexin43)IBA
08/2005 - 05/2005
1RNA (Ribonucleic Acid)IBA
10/2021
1UbiquitinIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1CollagenIBA
10/2018
1CytokinesIBA
10/2018
1TOR Serine-Threonine KinasesIBA
10/2017
1MMI-0100IBA
09/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1ReninIBA
01/2017
1CreatinineIBA
01/2017
1Lipocalin-2IBA
01/2017
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
04/2016
15-nitro-2-(3-phenylpropylamino)benzoic acidIBA
12/2014
1Natriuretic PeptidesIBA
12/2014
1OsteopontinIBA
12/2014
1N-propionylprocainamideIBA
12/2014
1TubulinIBA
12/2014
1TropomyosinIBA
04/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2014
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
08/2013
1Beclin-1IBA
06/2013
1NucleotidesIBA
01/2013
1Adenosine Diphosphate (ADP)IBA
01/2013
1Glucose (Dextrose)FDA LinkGeneric
03/2012
1Mechanistic Target of Rapamycin Complex 1IBA
03/2012

Therapy/Procedure

5Therapeutics
08/2017 - 11/2003
1Surgical Amputation (Amputations)
01/2021
1Caloric Restriction
10/2017